Fig. 1From: Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trialPlace of the amyloid plasma analysis in relation to MAPT and ancillary studies. MAPT multidomain Alzheimer’s preventive trialBack to article page